Aaron Vandervelde discussed “Contract Pharmacy Arrangements: Implications for Stakeholders” on October 12. Topics included:
- What are all the different ways in which the policy implementations around these arrangements could play out?
- How are stakeholders going to be affected?
- What does it look like from a PBM perspective?
- How does it change for different companies: specialty portfolio versus retail portfolio etc.?
- What are some strategies for long-term solutions?
Find out more. BRG was a proud sponsor and supporter of the MDRP conference.